MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Cassava Sciences Inc

Ouvert

SecteurSoins de santé

1.61 -3.59

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.58

Max

1.69

Chiffres clés

By Trading Economics

Revenu

346K

-28M

BPA

-0.57

Employés

30

EBITDA

1.4M

-30M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+20.48% upside

Dividendes

By Dow Jones

Prochains Résultats

8 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-49M

71M

Ouverture précédente

5.2

Clôture précédente

1.61

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

Cassava Sciences Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

27 sept. 2024, 10:48 UTC

Principaux Mouvements du Marché

Cassava Sciences Shares Lower Premarket on $40 Million Penalty to Settle Doctored Data Claims

28 juin 2024, 20:15 UTC

Principaux Mouvements du Marché

Cassava Sciences' Shares Down 46% After Adviser Is Indicted

27 sept. 2024, 18:36 UTC

Résultats

These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More -- Barrons.com

27 sept. 2024, 09:15 UTC

Actions en Tendance

Stocks to Watch Friday: Bristol Myers Squibb, EchoStar, Costco -- WSJ

Comparaison

Variation de prix

Cassava Sciences Inc prévision

Objectif de Prix

By TipRanks

20.48% hausse

Prévisions sur 12 Mois

Moyen 2 USD  20.48%

Haut 2 USD

Bas 2 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

2 ratings

0

Achat

1

Maintien

1

Vente

Score Technique

By Trading Central

1.37 / 1.66Support & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.